Effectiveness of inspiratory muscle trainer on pulmonary function and functional capacities in phase 1 cardiac rehabilitation
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 130
- 试验地点
- 1
- 主要终点
- Inspiratory muscle trainer
研究概览
简要总结
Cardiac rehabilitation is defined by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) as the delivery of all-inclusive, long-term services that include medical evaluation, prescription exercise, modification of cardiac risk factors, education, counseling, and behavioral interventions. The inspiratory muscle trainer device benefits includes improved pulmonary function, respiratory muscle strength and endurance, functional capacity, physical activity, and health-related quality of life used patients.Efficacy of inspiratory muscle trainer during Phase 1 of cardiac rehabilitation has not been well studied.
This randomized clinical trial aimed to evaluate and the effects of Inspiratory muscle trainer who underwent Phase 1 of their cardiac rehabilitation.
Procedure : Participants will be selected and screened based on inclusion and exclusion criteria. Details about the study and intervention will be explained to the participants and an informed written consent form will be obtained. Patient’s will be Randomly divided through block randomisation method into Group A (control ) and Group B ( IMT). Outcomes will be assessed on pod 1 and treatment will be given from POD 2 to POD 6 to Patients who underwent through cardiac rehabilitation On Postoperative day 6 outcomes will be reassessed. Data will be collected from both groups and analyzed for significant differences in pulmonary function and airway clearance improvements. Statistical tests will be used to compare the efficacy of inspiratory muscle trainer devices in enhancing respiratory outcomes in phase 1 cardiac rehab patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •1 A minimum 40% ejection fraction 2 Heart valve surgery, left or right 3 Minimum age of eighteen years 4 NYHA I–III stable heart failure CABG 5 Coronary artery percutaneous intervention.
排除标准
- •BP higher than 200mg in systolic and 110 in diastolic ,ischemic ECG alteration, uncontrolled tachycardia instable angina, AV block of third degree.
结局指标
主要结局
Inspiratory muscle trainer
时间窗: Postoperative day 1 | Postoperative day 6
次要结局
- 6 Minute walk test(Postoperative day 1)
研究者
Dr Nigam Subhash Nagdeve
Datta Meghe College Of Physiotherapy ,Nagpur
